These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 27045975)
1. Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases. Kumar R; Juillerat-Jeanneret L; Golshayan D J Med Chem; 2016 Sep; 59(17):7719-37. PubMed ID: 27045975 [TBL] [Abstract][Full Text] [Related]
2. Notch Signalling Pathways and Their Importance in the Treatment of Cancers. Teoh SL; Das S Curr Drug Targets; 2018; 19(2):128-143. PubMed ID: 28294046 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies. Nefedova Y; Gabrilovich D Drug Resist Updat; 2008 Dec; 11(6):210-8. PubMed ID: 18951834 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic approaches to modulating Notch signaling: current challenges and future prospects. Groth C; Fortini ME Semin Cell Dev Biol; 2012 Jun; 23(4):465-72. PubMed ID: 22309842 [TBL] [Abstract][Full Text] [Related]
6. Notch Signaling: A Potential Therapeutic Target for Hematologic Malignancies. Gao L; Yuan K; Ding W; Lin M Crit Rev Eukaryot Gene Expr; 2016; 26(3):239-46. PubMed ID: 27650987 [TBL] [Abstract][Full Text] [Related]
7. Emerging roles of the γ-secretase-notch axis in inflammation. Cheng YL; Choi Y; Sobey CG; Arumugam TV; Jo DG Pharmacol Ther; 2015 Mar; 147():80-90. PubMed ID: 25448038 [TBL] [Abstract][Full Text] [Related]
8. NOTCH signaling as a novel cancer therapeutic target. Miele L; Miao H; Nickoloff BJ Curr Cancer Drug Targets; 2006 Jun; 6(4):313-23. PubMed ID: 16848722 [TBL] [Abstract][Full Text] [Related]
9. Notch signaling, gamma-secretase inhibitors, and cancer therapy. Shih IeM; Wang TL Cancer Res; 2007 Mar; 67(5):1879-82. PubMed ID: 17332312 [TBL] [Abstract][Full Text] [Related]
10. Notch signaling: an emerging therapeutic target for cancer treatment. Yuan X; Wu H; Xu H; Xiong H; Chu Q; Yu S; Wu GS; Wu K Cancer Lett; 2015 Dec; 369(1):20-7. PubMed ID: 26341688 [TBL] [Abstract][Full Text] [Related]
11. Targeting the Notch Signaling Pathway in Chronic Inflammatory Diseases. Christopoulos PF; Gjølberg TT; Krüger S; Haraldsen G; Andersen JT; Sundlisæter E Front Immunol; 2021; 12():668207. PubMed ID: 33912195 [TBL] [Abstract][Full Text] [Related]
12. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials. Shi W; Harris AL J Mammary Gland Biol Neoplasia; 2006 Jan; 11(1):41-52. PubMed ID: 16947085 [TBL] [Abstract][Full Text] [Related]
14. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716 [TBL] [Abstract][Full Text] [Related]
15. Notch -- a goldilocks signaling pathway in disease and cancer therapy. Braune EB; Lendahl U Discov Med; 2016 Mar; 21(115):189-96. PubMed ID: 27115169 [TBL] [Abstract][Full Text] [Related]
16. Gamma-secretase and the intramembrane proteolysis of Notch. Jorissen E; De Strooper B Curr Top Dev Biol; 2010; 92():201-30. PubMed ID: 20816396 [TBL] [Abstract][Full Text] [Related]
17. Small molecules that inhibit Notch signaling. De Kloe GE; De Strooper B Methods Mol Biol; 2014; 1187():311-22. PubMed ID: 25053499 [TBL] [Abstract][Full Text] [Related]